MENU
DSGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Design Therapeutics (DSGN) Ownership - Who owns Design Therapeutics?
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations... Show more
Profile
Industry
N/A
Address
6005 Hidden Valley Road
Phone
+1 858 293-4900
Employees
124
Web
https://www.designtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
202.66M
P/E Ratio
N/A
Total Cash
229.67M
Projected Growth
N/A
Total Debt
2.14M
Revenue
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash/Share
4.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DSGN
Capitalization
203M
P/E Ratio
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash
230M
Total Cash/Share
4.05
Total Debt
2.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
228M
P/B Ratio
0.89
Cash Flow
N/A
Earnings
-0.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
28.37
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-67.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.77
Shares Held By Institutions
162M
Shares Outstanding - Current
56.8M
Total Liabilities
9.56M
Total Volume MTD
N/A
Value
-1
Gain YTD
-42.139
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6005 Hidden Valley Road
Phone
+1 858 293-4900
Employees
124
Web
https://www.designtx.com